Fresenius Medical Care
€39.55Change from previous close: −0.33%Absolute change: −€0.13
At a glance
- Revenue growth
- +1.51%
- 2025 vs 2024
- Net income growth
- +81.88%
- 2025 vs 2024
- Net margin
- 5.0%
- 2024: 2.8%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | 19,628 | 19,336 | 19,454 | 19,398 |
| Cost of revenue | 14,599 | 14,579 | 14,529 | 14,504 |
| Gross profit | 5,029 | 4,757 | 4,925 | 4,894 |
| Selling, general and administrative | 3,033 | 3,143 | 3,196 | 3,170 |
| Research and development | 158 | 183 | 232 | 229 |
| Operating income | 1,827 | 1,467 | 1,477 | 1,455 |
| EBIT | 1,897 | 1,464 | 1,458 | 1,579 |
| EBITDA | 3,397 | 3,206 | 3,210 | 3,418 |
| Interest expense | 384 | 407 | 425 | 360 |
| Pre-tax income | 1,512 | 1,057 | 1,033 | 1,219 |
| Income tax | 321 | 316 | 301 | 325 |
| Net income | 978 | 538 | 499 | 673 |
| Net income to common shareholders | 978 | 538 | 499 | 673 |
| Basic EPS | 3.36 | 1.83 | 1.70 | 2.30 |
| Diluted EPS | 3.36 | 1.83 | 1.70 | 2.30 |
| Average shares (basic) | 291 | 293 | 293 | 293 |
| Average shares (diluted) | 291 | 293 | 293 | 293 |